Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia
Abstract
1. Introduction
2. Antibiotic Resistance in S. aureus
2.1. Vancomycin’s Mechanism of Action against S. aureus and the Emergence of Resistance
2.2. Interpretation Criteria for Vancomycin-Susceptible S. aureus
2.3. Selection Criteria
3. Vancomycin Non-Susceptible S. aureus in South Asia
3.1. Pakistan
3.2. India
3.3. Bangladesh
3.4. Sri Lanka
3.5. Nepal
3.6. Afghanistan
Country | Study Period | Isolation Site | No. of Positive VRSA/Total | No. of Positive VISA/Total | No. of Positive hVISA/Total | Genetic Marker (vanA/vanB/icaA) | Molecular Typing | Reference |
---|---|---|---|---|---|---|---|---|
Pakistan | 2020 | Pus, skin wound, CSF | 113/200 | --- | --- | --- | --- | [69] |
Pakistan | February 2017–March 2018 | Pus swabs from diabetic foot ulcers, wounds, breast abscesses | 565/6780 | 792/6780 | --- | --- | --- | [67] |
Pakistan | January 2010–December 2010 | Pus, urine, blood, vaginal swab, and other secretions | 1/174 | 4/174 | --- | --- | --- | [66] |
Pakistan | 2016 | Pus | 22/110 | 5/110 | --- | --- | --- | [70] |
Pakistan | 2017–2018 | Blood, body fluid, pus, skin wound | 14/100 | --- | --- | vanA | --- | [101] |
Pakistan | 2016 | Pus from ear, skin wound | 11/150 | --- | --- | vanA | --- | [64] |
Pakistan | 2011 | Blood | 1/1 | --- | --- | vanA, icaA | --- | [65] |
Pakistan | 2015 | Wound, pus swab | 5/51 | --- | --- | --- | --- | [102] |
Nepal | Blood, urine, sputum, catheter swab, pus, and body fluids | 2/57 | 31/57 | --- | --- | --- | [103] | |
Nepal | 2010 | Lacrimal swabs from chronic dacryocystitis | 22/27 | --- | --- | --- | --- | [92] |
Nepal | November 2011–May 2012 | Urine, blood, and body fluids | --- | 4/45 | --- | --- | --- | [93] |
India | January 1997–March 2000 | Clinical isolates | --- | --- | 5/80 | --- | --- | [76] |
India | August 2002–July 2005 | Pus, urine, wound swabs, catheters, blood, sputum, and CSF | 2/783 | 6/783 | --- | 0 | --- | [104] |
India | 2016 | Dental caries | 27/150 | --- | --- | 13 (vanA) 2(vanB) | --- | [105] |
India | July 2010–September 2012 | Pus, urine, wound swabs, catheters, blood, and sputum | 7/115 | 53/115 | --- | --- | --- | [74] |
India | March 2008–October 2008 | Blood, urine and throat swabs, wounds, and ear swabs | 7/358 | 16/358 | --- | 6 (vanA) | --- | [106] |
India | May 2013–October 2013 | Clinical samples | 3/100 | 12/100 | 6/100 | --- | --- | [107] |
India | July 2009–December 2012 | Surgical site infection | 0/267 | 3/267 | --- | --- | --- | [108] |
India | January 2014–December 2016 | Clinical samples | --- | --- | 66/500 | --- | SCCmec III (8%), SCCmec IV (17.7%), SCCmec V (50%) | |
India | July 2015–June 2016 | Pus, respiratory tract, urine, blood, body fluids, and catheter tips | --- | 18/266 | 15/266 | --- | NA | [75] |
India | February 2019–March 2020 | Pus, tissue, blood, catheter | --- | --- | 14/220 | --- | --- | [80] |
Sri Lanka | April 2002 | Surgical site infection | --- | 1/1 | --- | --- | --- | [87] |
Bangladesh | August 2010–July 2011 | Clinical samples | 114/122 | --- | --- | --- | ||
Bangladesh | January 2010–December 2011 | Clinical samples | 3/38 | --- | --- | --- | --- | [109] |
Bangladesh | July 2011–June 2012 | Wound swabs | 2/15 | --- | --- | vanB | --- | [81] |
Bangladesh | April 2012–January 2013 | Burn wounds | --- | 16/29 | --- | --- | --- | [19] |
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Hemmadi, V.; Biswas, M. An overview of moonlighting proteins in Staphylococcus aureus infection. Arch. Microbiol. 2020, 203, 481–498. [Google Scholar] [CrossRef]
- Lowy, F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339, 2025–2027. [Google Scholar] [CrossRef]
- Abbasian, S.; Farahani, N.; Mir, Z.; Alinejad, F.; Haeili, M.; Dahmardehei, M.; Mirzaii, M.; Khoramrooz, S.; Nasiri, M.; Darban-Sarokhalil, D. Genotypic characterization of Staphylococcus aureus isolated from a burn centre by using agr, spa and SCCmec typing methods. New Microbes New Infect. 2018, 26, 15–19. [Google Scholar] [CrossRef]
- Mitchell, D.H.; Howden, B. Diagnosis and management of Staphylococcus aureus bacteraemia. Intern. Med. J. 2005, 35, S17–S24. [Google Scholar] [CrossRef]
- McGuinness, W.A.; Malachowa, N.; DeLeo, F.R. Focus: Infectious diseases: Vancomycin resistance in Staphylococcus aureus. Yale J. Biol. Med. 2017, 90, 269. [Google Scholar]
- Huttner, A.; Harbarth, S.; Carlet, J.; Cosgrove, S.; Goossens, H.; Holmes, A.; Jarlier, V.; Voss, A.; Pittet, D. Antimicrobial resistance: A global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob. Resist. Infect. Control 2013, 2, 31. [Google Scholar] [CrossRef][Green Version]
- Bamigboye, B.T.; Olowe, O.A.; Taiwo, S.S. Phenotypic and molecular identification of vancomycin resistance in clinical Staphylococcus aureus isolates in Osogbo, Nigeria. Eur. J. Microbiol. Immunol. 2018, 8, 25–30. [Google Scholar] [CrossRef]
- Makgotlho, P.E.; Kock, M.; Hoosen, A.; Lekalakala, R.; Omar, S.V.; Dove, M.; Ehlers, M.M. Molecular identification and genotyping of MRSA isolates. FEMS Immunol. Med. Microbiol. 2009, 57, 104–115. [Google Scholar] [CrossRef][Green Version]
- Chen, C.-J.; Huang, Y.-C. New epidemiology of Staphylococcus aureus infection in Asia. Clin. Microbiol. Infect. 2014, 20, 605–623. [Google Scholar] [CrossRef][Green Version]
- Nelwan, E.J.; Andayani, D.; Clarissa, G.; Pramada, T. Vancomycin-resistant Staphylococcus aureus infection post-liposuction in South Korea. Cureus 2021, 13, e14357. [Google Scholar] [CrossRef]
- Hanaki, H.; Hososaka, Y.; Yanagisawa, C.; Nakae, T.; Sunakawa, K.; Otsuka, Y.; Nagasawa, Z. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan. J. Infect. Chemother. 2007, 13, 118–121. [Google Scholar] [CrossRef] [PubMed]
- Berglee, R. World Regional Geography: People, Places and Globalization; University of Minnesota Libraries Publishing: Minneapolis, MN, USA, 2012. [Google Scholar]
- Worldometer. Southern Asia Population. 4 April 2021. Available online: https://www.worldometers.info/world-population/southern-asia-population/ (accessed on 4 April 2022).
- Zaidi, S.; Saligram, P.; Ahmed, S.; Sonderp, E.; Sheikh, K. Expanding access to healthcare in South Asia. Br. Med. J. 2017, 357, j1645. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Cong, Y.; Yang, S.; Rao, X. Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. J. Adv. Res. 2020, 21, 169–176. [Google Scholar] [CrossRef]
- Saha, B.; Singh, A.K.; Ghosh, A.; Bal, M. Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J. Med. Microbiol. 2008, 57, 72–79. [Google Scholar] [CrossRef] [PubMed]
- Wu, Q.; Sabokroo, N.; Wang, Y.; Hashemian, M.; Karamollahi, S.; Kouhsari, E. Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates. Antimicrob. Resist. Infect. Control 2021, 10, 101. [Google Scholar] [CrossRef] [PubMed]
- Riaz, S.; Hussain, A.; Sohail, M.; Rehman, S.U.; Javed, N.; Abbas, Z. Isolation and characterization of Vancomycin-Resistant Staphylococcus aureus (VRSA) from Intensive Care Units (ICU) of different hospitals in Lahore, Pakistan. Adv. Life Sci. 2021, 8, 339–344. [Google Scholar]
- Hasan, R.; Acharjee, M.; Noor, R. Prevalence of Vancomycin-Resistant Staphylococcus aureus (VRSA) in Methicillin-Resistant S. aureus (MRSA) strains isolated from burn wound infections. Tzu Chi Med. J. 2016, 28, 49–53. [Google Scholar] [CrossRef][Green Version]
- Shariati, A.; Dadashi, M.; Moghadam, M.T.; van Belkum, A.; Yaslianifard, S.; Darban-Sarokhalil, D. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: A systematic review and meta-analysis. Sci. Rep. 2020, 10, 12698. [Google Scholar] [CrossRef]
- Stepanović, S.; Dakić, I.; Djukić, S.; Lozuk, B.; Svabić-Vlahović, M. Surgical wound infection associated with Staphylococcus sciuri. Scand. J. Infect. Dis. 2002, 34, 685–686. [Google Scholar] [CrossRef]
- Gill, S.R.; Fouts, D.E.; Archer, G.L.; Mongodin, E.F.; DeBoy, R.T.; Ravel, J.; Paulsen, I.T.; Kolonay, J.F.; Brinkac, L.; Beanan, M.; et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 2005, 187, 2426–2438. [Google Scholar] [CrossRef][Green Version]
- Chambers, H.F.; DeLeo, F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 2009, 7, 629–641. [Google Scholar] [CrossRef] [PubMed]
- Rammelkamp, C.H.; Maxon, T. Resistance of Staphylococcus aureus to the action of penicillin. Proc. Soc. Exp. Biol. Med. 1942, 51, 386–389. [Google Scholar] [CrossRef]
- Olsen, J.E.; Christensen, H.; Aarestrup, F.M. Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. J. Antimicrob. Chemother. 2006, 57, 450–460. [Google Scholar] [CrossRef] [PubMed]
- Jevons, M.P. “Celbenin”-resistant staphylococci. Br. Med. J. 1961, 1, 124. [Google Scholar] [CrossRef]
- Baede, V.O.; David, M.Z.; Andrasevic, A.T.; Blanc, D.S.; Borg, M.; Brennan, G.; Catry, B.; Chabaud, A.; Empel, J.; Enger, H.; et al. MRSA surveillance programmes worldwide: Moving towards a harmonised international approach. Int. J. Antimicrob. Agents 2022, 59, 106538. [Google Scholar] [CrossRef] [PubMed]
- Klein, E.; Smith, D.L.; Laxminarayan, R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg. Infect. Dis. 2007, 13, 1840. [Google Scholar] [CrossRef]
- Tang, J.; Hu, J.; Kang, L.; Deng, Z.; Wu, J.; Pan, J. The use of vancomycin in the treatment of adult patients with methicillin-resistant Staphylococcus aureus (MRSA) infection: A survey in a tertiary hospital in China. Int. J. Clin. Exp. Med. 2015, 8, 19436. [Google Scholar]
- Klevens, R.M.; Morrison, M.A.; Nadle, J.; Petit, S.; Gershman, K.; Ray, S.; Harrison, L.H.; Lynfield, R.; Dumyati, G.; Townes, J.M.; et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J. Am. Med. Assoc. 2007, 298, 1763–1771. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Tsuzuki, S.; Matsunaga, N.; Yahara, K.; Gu, Y.; Hayakawa, K.; Hirabayashi, A.; Kajihara, T.; Sugai, M.; Shibayama, K.; Ohmagari, N. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan. J. Infect. Chemother. 2020, 26, 367–371. [Google Scholar] [CrossRef]
- Ruhe, J.J.; Smith, N.; Bradsher, R.W.; Menon, A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: Impact of antimicrobial therapy on outcome. Clin. Infect. Dis. 2007, 44, 777–784. [Google Scholar] [CrossRef][Green Version]
- Foster, T.J.; Geoghegan, J.A. Staphylococcus aureus. In Molecular Medical Microbiology, 4th ed.; Baron, S., Ed.; University of Texas Medical Branch: Galveston, TX, USA, 2015; pp. 655–674. [Google Scholar]
- Japoni, A.; Jamalidoust, M.; Farshad, S.; Ziyaeyan, M.; Alborzi, A.; Japoni, S.; Rafaatpour, N. Characterization of SCCmec types and antibacterial susceptibility patterns of methicillin-resistant Staphylococcus aureus in Southern Iran. Jpn. J. Infect. Dis. 2011, 64, 28–33. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.; Chen, D.; Peters, B.M.; Li, L.; Li, B.; Xu, Z.; Shirliff, M.E. Staphylococcal chromosomal cassettes mec (SCCmec): A mobile genetic element in methicillin-resistant Staphylococcus aureus. Microb. Pathog. 2016, 101, 56–67. [Google Scholar] [CrossRef] [PubMed]
- Foster, T.J. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol. Rev. 2017, 41, 430–449. [Google Scholar] [CrossRef]
- Chongtrakool, P.; Ito, T.; Ma, X.X.; Kondo, Y.; Trakulsomboon, S.; Tiensasitorn, C.; Hiramatsu, K. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: A proposal for a new nomenclature for SCCmec elements. Antimicrob. Agents Chemother. 2006, 50, 1001–1012. [Google Scholar] [CrossRef][Green Version]
- Peng, H.; Liu, D.; Ma, Y.; Gao, W. Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus isolates at a Chinese tertiary hospital, 2012–2017. Sci. Rep. 2018, 8, 17916. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Kateete, D.P.; Bwanga, F.; Seni, J.; Mayanja, R.; Kigozi, E.; Mujuni, B.; Ashaba, F.K.; Baluku, H.; Najjuka, C.F.; Källander, K.; et al. CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda. Antimicrob. Resist. Infect. Control 2019, 8, 94. [Google Scholar] [CrossRef] [PubMed]
- Hu, Q.; Cheng, H.; Yuan, W.; Zeng, F.; Shang, W.; Tang, D.; Xue, W.; Fu, J.; Zhou, R.; Zhu, J.; et al. Panton-Valentine Leukocidin (PVL)-positive health care-associated methicillin-resistant Staphylococcus aureus isolates are associated with skin and soft tissue infections and colonized mainly by infective PVL-encoding bacteriophages. J. Clin. Microbiol. 2015, 53, 67–72. [Google Scholar] [CrossRef][Green Version]
- Rehm, S.J.; Tice, A. Staphylococcus aureus: Methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Clin. Infect. Dis. 2010, 51 (Suppl. S2), S176–S182. [Google Scholar]
- Hiramatsu, K.; Hanaki, H.; Ino, T.; Yabuta, K.; Oguri, T.; Tenover, F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 1997, 40, 135–136. [Google Scholar] [CrossRef][Green Version]
- Goldrick, B. First reported case of VRSA in the United States: An alarming development in microbial resistance. AJN Am. J. Nurs. 2002, 102, 17. [Google Scholar] [CrossRef]
- Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. MMWR. Morb. Mortal. Wkly. Rep. 1997, 46, 813–815.
- Hallin, M.; Friedrich, A.W.; Struelens, M.J. spa typing for epidemiological surveillance of Staphylococcus aureus. Mol. Epidemiol. Microorg. Methods Protocols 2009, 551, 189–202. [Google Scholar]
- Larsen, M.V.; Cosentino, S.; Rasmussen, S.; Friis, C.; Hasman, H.; Marvig, R.L.; Jelsbak, L.; Sicheritz-Pontéen, T.; Ussery, D.W.; Aarestrup, F.M.; et al. Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 2012, 50, 1355–1361. [Google Scholar] [CrossRef][Green Version]
- Shekarabi, M.; Hajikhani, B.; Chirani, A.S.; Fazeli, M.; Goudarzi, M. Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three-year study in Tehran, Iran. PLoS ONE 2017, 12, e0183607. [Google Scholar] [CrossRef][Green Version]
- Monecke, S.; Coombs, G.; Shore, A.C.; Coleman, D.C.; Akpaka, P.; Borg, M.; Chow, H.; Ip, M.; Jatzwauk, L.; Jonas, D.; et al. A Field Guide to Pandemic, Epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS ONE 2011, 6, e17936. [Google Scholar]
- Bozdogan, B.; Ednie, L.; Credito, K.; Kosowska, K.; Appelbaum, P.C. Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center. Antimicrob. Agents Chemother. 2004, 48, 4762–4765. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Howden, B.P.; Seemann, T.; Harrison, P.F.; McEvoy, C.R.; Stanton JA, L.; Rand, C.J.; Stinear, T.P. Complete genome sequence of Staphylococcus aureus strain JKD6008, an ST239 clone of methicillin-resistant Staphylococcus aureus with intermediate-level vancomycin resistance. J. Bacteriol. 2010, 192, 5848–5849. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Howden, B.P.; Davies, J.K.; Johnson, P.D.R.; Stinear, T.P.; Grayson, M.L. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 2010, 23, 99–139. [Google Scholar] [CrossRef][Green Version]
- Arthur, M.; Molinas, C.; Depardieu, F.; Courvalin, P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 1993, 175, 117–127. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Périchon, B.; Courvalin, P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53, 4580–4587. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Gilmore, M.S.; Clewell, D.B.; Ike, Y.; Shankar, N. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection [Internet]; Massachusetts Eye and Ear Infirmary: Boston, MA, USA, 2014. [Google Scholar]
- Weinstein, R.A.; Fridkin, S.K. Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know. Clin. Infect. Dis. 2001, 32, 108–115. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Pillai, S.K.; Wennersten, C.; Venkataraman, L.; Eliopoulos, G.M.; Moellering, J.R.C.; Karchmer, A.W. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin. Infect. Dis. 2009, 49, 1169–1174. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Gardete, S.; Kim, C.; Hartmann, B.M.; Mwangi, M.; Roux, C.M.; Dunman, P.M.; Chambers, H.F.; Tomasz, A. Genetic pathway in acquisition and loss of vancomycin resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog. 2012, 8, e1002505. [Google Scholar]
- Wang, W.-Y.; Lee, S.-Y.; Chiueh, T.-S.; Lu, J.-J. Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate Staphylococcus aureus isolates from patients with septic arthritis. J. Clin. Microbiol. 2009, 47, 3617–3623. [Google Scholar]
- Holmes, N.E.; Turnidge, J.D.; Munckhof, W.J.; Robinson, J.O.; Korman, T.; O’Sullivan, M.; Anderson, T.L.; Roberts, S.A.; Gao, W.; Christiansen, K.J.; et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J. Infect. Dis. 2011, 204, 340–347. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Haripur District Demographics. 17 May 2022. Available online: https://kp.gov.pk/page/haripurdistrictdemographics (accessed on 17 May 2022).
- Wang, G.; Hindler, J.F.; Ward, K.W.; Bruckner, D.A. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-Year Period. J. Clin. Microbiol. 2006, 44, 3883–3886. [Google Scholar] [CrossRef][Green Version]
- Tenover, F.C.; Moellering, R.C., Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin. Infect. Dis. 2007, 44, 1208–1215. [Google Scholar] [CrossRef] [PubMed]
- Edition, A.S.N. CLSI Document M07-A9; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2012. [Google Scholar]
- Azhar, A.; Rasool, S.; Haque, A.; Shan, S.; Saeed, M.; Ehsan, B.; Haque, A. Detection of high levels of resistance to linezolid and vancomycin in Staphylococcus aureus. J. Med. Microbiol. 2017, 66, 1328–1331. [Google Scholar] [CrossRef]
- Mirani, Z.A.; Jamil, N. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus. J. Basic Microbiol. 2011, 51, 191–195. [Google Scholar] [CrossRef]
- Taj, Y.; Abdullah, F.E.; Kazmi, S.U. Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance. J. Coll. Physicians Surg. Pak. 2010, 20, 728–732. [Google Scholar]
- Ahmad, S.; Ahmed, S.; Sabir, M.; Khan, H.; Rehman, M.; Niaz, Z. Frequency and comparison among antibiotic resistant Staphylococcus aureus strains in selected hospitals of Peshawar, Pakistan. J. Pak. Med. Assoc. 2020, 70, 1199–1202. [Google Scholar] [CrossRef]
- Hakim, S.T.; Arshed, S.; Iqbal, M.; Javaid, S.G. Vancomycin sensitivity of Staphylococcus aureus isolates from hospital patients in Karachi, Pakistan. Libyan J. Med. 2007, 2, 176–179. [Google Scholar] [CrossRef] [PubMed]
- Saeed, A.; Ahsan, F.; Nawaz, M.; Iqbal, K.; Rehman, K.U.; Ijaz, T. Incidence of vancomycin resistant phenotype of the Methicillin Resistant Staphylococcus aureus isolated from a tertiary care hospital in Lahore. Antibiotics 2019, 9, 3. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Ghias, W.; Sharif, M.; Yazdani, F.A.; Rabbani, M. Isolation and identification of methicillin and vancomycin resistance Staphylococcus aureus from pus samples of injured skin patients in Lahore, Pakistan. Biomed. Lett. 2016, 2, 103–112. [Google Scholar]
- Hanif, E.; Hassan, S.A. Evaluation of antibiotic resistance pattern in clinical isolates of Staphylococcus aureus. Pak. J. Pharm. Sci. 2019, 32, 1749–1753. [Google Scholar] [PubMed]
- Banerjee, T.; Anupurba, S. Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center in North India. J. Clin. Microbiol. 2012, 50, 1730–1732. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Goud, R.; Gupta, S.; Neogi, U.; Agarwal, D.; Naidu, K.; Chalannavar, R.; Subhaschandra, G. Community prevalence of methicillin and vancomycin resistant Staphylococcus aureus in and around Bangalore, southern India. Rev. da Soc. Bras. de Med. Trop. 2011, 44, 309–312. [Google Scholar] [CrossRef][Green Version]
- Moses, V.K.; Kandi, V.; Rao, S.K.D. Minimum inhibitory concentrations of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolated from various clinical specimens: A study from South India. Cureus 2020, 12, e6749. [Google Scholar] [CrossRef][Green Version]
- Mohanty, S.; Behera, B.; Sahu, S.; Praharaj, A.K. Recent pattern of antibiotic resistance in Staphylococcus aureus clinical isolates in Eastern India and the emergence of reduced susceptibility to vancomycin. J. Lab. Physicians 2019, 11, 340–345. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Song, J.-H.; Hiramatsu, K.; Suh, J.Y.; Ko, K.S.; Ito, T.; Kapi, M.; Kiem, S.; Kim, Y.-S.; Oh, W.S.; Peck, K.R.; et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 2004, 48, 4926–4928. [Google Scholar] [CrossRef][Green Version]
- Chung, D.R.; Lee, C.; Kang, Y.R.; Baek, J.Y.; Kim, S.H.; Ha, Y.E.; Kang, C.-I.; Peck, K.R.; Lee, N.Y.; Song, J.-H. Genotype-specific prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in Asian countries. Int. J. Antimicrob. Agents 2015, 46, 338–341. [Google Scholar] [CrossRef]
- Sistla, S.; Amberpet, R.; Sugumar, M.; Nagasundaram, N.; Manoharan, M.; Parija, S.C. Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: A preliminary report from south India. Indian J. Med. Res. 2019, 150, 194–198. [Google Scholar] [CrossRef]
- Selvabai, A.P.; Sattar, S.B.A.; Jayaraman, P.; Shanmugam, P. Detection and characterisation of heteroresistant Vancomycin Intermediate Staphylococcus aureus (hVISA) using phenotypic and genotypic methods. J. Clin. Diagn. Res. 2019, 13, 1–5. [Google Scholar] [CrossRef]
- Sreejisha, M.; Mulki, S.S.; Shenoy, S.; Dhanashree, B.; Chakrapani, M.; Bhat, G. Heterogeneous vancomycin intermediate Staphylococcus aureus infections in diabetic and non-diabetic patients–A hospital-based comparative study. Infect. Drug Resist. 2023, 16, 9–17. [Google Scholar]
- Islam, T.A.B.; Shamsuzzaman, S. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant, vancomycin-resistant, and Panton-Valentine Leukocidin positive Staphylococcus aureus in a tertiary care hospital Dhaka, Bangladesh. Tzu Chi Med. J. 2015, 27, 10–14. [Google Scholar] [CrossRef][Green Version]
- Shahriar, M.; Shahid, S.; Katha, K.K.; Nasreen, W.; Bhuiyan, M.A. Vancomycin sensitivity of clinical isolates of Staphylococcus aureus from patients in Dhaka City, Bangladesh. Bangladesh Pharm. J. 2012, 15, 159–163. [Google Scholar] [CrossRef][Green Version]
- Haque, N.; Aung, M.S.; Paul, S.K.; Bari, S.; Ahmed, S.; Sarkar, S.R.; Roy, S.; Nasreen, S.A.; Mahmud, M.C.; Hossain, M.A.; et al. Molecular epidemiological characterization of methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin and soft tissue infections in Bangladesh. Microb. Drug Resist. 2019, 25, 241–250. [Google Scholar] [CrossRef]
- Taz, K.A.; Jobayer, M.; Shamsuzzaman, S.M. Nasal colonization of methicillin resistant Staphylococcus aureus among healthcare providers in a tertiary care hospital, Bangladesh. Mymensingh Med. J. MMJ 2019, 28, 627–633. [Google Scholar] [PubMed]
- Roy, S.; Barman, T.K.; Hossain, M.A.; Paul, S.K.; Haque, N.; Ahmed, S.; Nasreen, S.A.; Hossain, M.S.; Sarkar, S.R.; Kubayashi, N.; et al. Molecular-characterization of Methicillin-Resistance Staphylococcus aureus (MRSA) from different tertiary care hospitals in Bangladesh. Mymensingh Med. J. 2017, 26, 37–44. [Google Scholar]
- Parvez, M.A.K.; Ferdous, R.N.; Rahman, M.S.; Islam, S. Healthcare-associated (HA) and community-associated (CA) methicillin resistant Staphylococcus aureus (MRSA) in Bangladesh–Source, diagnosis and treatment. J. Genet. Eng. Biotechnol. 2018, 16, 473–478. [Google Scholar] [CrossRef] [PubMed]
- Song, J.-H.; Hsueh, P.-R.; Chung, D.R.; Ko, K.S.; Kang, C.-I.; Peck, K.R.; Yeom, J.-S.; Kim, S.-W.; Chang, H.-H.; Kim, Y.-S.; et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: An ANSORP study. J. Antimicrob. Chemother. 2011, 66, 1061–1069. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Jayaweera, J.; Karunarathne, M.; Kumbukgolla, W.W. The importance of timely introduction of vancomycin therapy against methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and severity of MRSA bacteremia at teaching hospital, Anuradhapura, Sri Lanka. Int J. One Health 2017, 3, 7–11. [Google Scholar] [CrossRef]
- Samaranayake, W.; Karunanayake, L.; Patabendige, C. Characteristics of community acquired and hospital acquired methicillin resistant Staphylococcus aureus isolates in the National Hospital of Sri Lanka. Sri Lankan J. Infect. Dis. 2019, 9, 24. [Google Scholar] [CrossRef]
- McTavish, S.M.; Snow, S.J.; Cook, E.C.; Pichon, B.; Coleman, S.; Coombs, G.W.; Pang, S.; Arias, C.A.; Díaz, L.; Boldock, E.; et al. Genomic and epidemiological evidence of a dominant Panton-Valentine Leucocidin-positive methicillin resistant Staphylococcus aureus lineage in Sri Lanka and presence among isolates from the United Kingdom and Australia. Front. Cell. Infect. Microbiol. 2019, 9, 123. [Google Scholar] [CrossRef] [PubMed]
- Wijitha Weerakoon, S.D.A.; Gamage, D.S.; Wijeratne, M. Staphylococcus aureus with reduced susceptibility to vancomycin. Ceylon Med. J. 2003, 48, 58–59. [Google Scholar] [CrossRef][Green Version]
- Chaudhary, M.; Bhattarai, A.; Adhikari, S.K.; Bhatta, D.R. Bacteriology and antimicrobial susceptibility of adult chronic dacryocystitis. Nepal. J. Ophthalmol. 2010, 2, 105–113. [Google Scholar] [CrossRef] [PubMed]
- Pahadi, P.C.; Shrestha, U.T.; Adhikari, N.; Shah, P.K.; Amatya, R. Growing resistance to vancomycin among methicillin resistant Staphylococcus aureus isolates from different clinical samples. J. Nepal Med. Assoc. 2014, 52, 977–981. [Google Scholar] [CrossRef]
- Raut, S.; Bajracharya, K.; Adhikari, J.; Pant, S.S.; Adhikari, B. Prevalence of methicillin resistant Staphylococcus aureus in Lumbini Medical College and Teaching Hospital, Palpa, Western Nepal. BMC Res. Notes 2017, 10, 187. [Google Scholar] [CrossRef]
- Shrestha, B.; Pokhrel, B.M.; Mohapatra, T.M. Phenotypic characterization of nosocomial isolates of Staphylococcus aureus with reference to MRSA. J. Infect. Dev. Ctries. 2009, 3, 554–560. [Google Scholar] [CrossRef][Green Version]
- Kshetry, A.O.; Pant, N.D.; Bhandari, R.; Khatri, S.; Shrestha, K.L.; Upadhaya, S.K.; Poudel, A.; Lekhak, B.; Raghubanshi, B.R. Minimum inhibitory concentration of vancomycin to methicillin resistant Staphylococcus aureus isolated from different clinical samples at a tertiary care hospital in Nepal. Antimicrob. Resist. Infect. Control 2016, 5, 27. [Google Scholar] [CrossRef][Green Version]
- Maharjan, M.; Sah, A.K.; Pyakurel, S.; Thapa, S.; Maharjan, S.; Adhikari, N.; Rijal, K.R.; Ghimire, P.; Shrestha, U.T. Molecular Confirmation of vancomycin-resistant Staphylococcus aureus with vanA gene from a hospital in Kathmandu. Int. J. Microbiol. 2021, 2021, 3847347. [Google Scholar] [CrossRef]
- Naimi, H.M.; Rasekh, H.; Noori, A.Z.; Bahaduri, M.A. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. BMC Infect. Dis. 2017, 17, 737. [Google Scholar] [CrossRef][Green Version]
- Naimi, H.M.; André, C.; Bes, M.; Tristan, A.; Gustave, C.-A.; Vandenesch, F.; Nazari, Q.A.; Laurent, F.; Dupieux, C. Antibiotic resistance profile and molecular characterization of Staphylococcus aureus strains isolated in hospitals in Kabul, Afghanistan. Eur. J. Clin. Microbiol. Infect. Dis. 2021, 40, 1029–1038. [Google Scholar] [CrossRef] [PubMed]
- Calhoun, J.H.; Murray, C.K.; Manring, M.M. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin. Orthop. Relat. Res. 2008, 466, 1356–1362. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Liaqat, F.; Sheikh, A.A.; Nazir, J.; Hussain, T.; Rabbani, M.; Shaheen, A.Y.; Muhammad, J. Report-Isolation, identification and control of vancomycin resistant Staphylococcus aureus. Pak. J. Pharm. Sci. 2015, 28, 997–1004. [Google Scholar]
- Lama, U.; Shah, D.; Shrestha, U.T. Vancomycin resistant Staphylococcus aureus reported from tertiary care hospital in Nepal. Tribhuvan Univ. J. Microbiol. 2017, 4, 63–72. [Google Scholar] [CrossRef][Green Version]
- Tiwari, H.K.; Sen, M.R. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect. Dis. 2006, 6, 156. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Vellappally, S.; Divakar, D.D.; Al Kheraif, A.A.; Ramakrishnaiah, R.; Alqahtani, A.; Dalati, M.H.N.; Anil, S.; Khan, A.A.; Varma, P.R.H. Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries. Acta Microbiol. Immunol. Hung. 2017, 64, 343–351. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Gaddad, S.M.; Thati, V.; Shivannavar, C.T. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J. Med. Res. 2011, 134, 704. [Google Scholar] [CrossRef]
- Bhattacharya, S.; Bir, R.; Majumdar, T. Evaluation of multidrug resistant Staphylococcus aureus and their association with biofilm production in a tertiary care hospital, Tripura, Northeast India. J. Clin. Diagn. Res. JCDR 2015, 9, DC01. [Google Scholar] [CrossRef]
- Bhattacharya, S.; Pal, K.; Jain, S.; Chatterjee, S.S.; Konar, J. Surgical site infection by methicillin resistant Staphylococcus aureus–On decline? J. Clin. Diagn. Res. JCDR 2016, 10, DC32. [Google Scholar] [CrossRef]
- Khanam, S.; Haq, J.A.; Shamsuzzaman, S.; Rahman, M.; Mamun, K.Z. Emergence of vancomycin resistant Staphylococcus aureus during hospital admission at a tertiary care hospital in Bangladesh. Bangladesh J. Infect. Dis. 2016, 3, 11–16. [Google Scholar] [CrossRef][Green Version]
- Rehman, T.U.; Aslam, R.; Aqib, A.I.; Mohsin, M.; Manzoor, A.; Shoaib, M.; Naseer, M.A.; Hassan, A.; Sattar, H.; Kulyar, M.F.-E.; et al. Phylogeny of hospital acquired MRSA, and its comparative phenotypic clinico-epidemiology with vancomycin resistant S. aureus (VRSA). Microb. Pathog. 2020, 149, 104537. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ejaz, M.; Syed, M.A.; Jackson, C.R.; Sharif, M.; Faryal, R. Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia. Antibiotics 2023, 12, 972. https://doi.org/10.3390/antibiotics12060972
Ejaz M, Syed MA, Jackson CR, Sharif M, Faryal R. Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia. Antibiotics. 2023; 12(6):972. https://doi.org/10.3390/antibiotics12060972
Chicago/Turabian StyleEjaz, Mohammad, Muhammad Ali Syed, Charlene R. Jackson, Mehmoona Sharif, and Rani Faryal. 2023. "Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia" Antibiotics 12, no. 6: 972. https://doi.org/10.3390/antibiotics12060972
APA StyleEjaz, M., Syed, M. A., Jackson, C. R., Sharif, M., & Faryal, R. (2023). Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia. Antibiotics, 12(6), 972. https://doi.org/10.3390/antibiotics12060972